These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 23250396

  • 21. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
    Le H, Arnold JT, McFann KK, Blackman MR.
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
    [Abstract] [Full Text] [Related]

  • 22. The role of the insulin-like growth factors in cancer.
    Le Roith D, Karas M, Yakar S, Qu BH, Wu Y, Blakesley VA.
    Isr Med Assoc J; 1999 Sep; 1(1):25-30. PubMed ID: 11370118
    [No Abstract] [Full Text] [Related]

  • 23. Insulin growth factor-I and epidermal growth factor receptors recruit distinct upstream signaling molecules to enhance AKT activation in mammary epithelial cells.
    Fleming JM, Desury G, Polanco TA, Cohick WS.
    Endocrinology; 2006 Dec; 147(12):6027-35. PubMed ID: 16990343
    [Abstract] [Full Text] [Related]

  • 24. Northwestern profiling of potential translation-regulatory proteins in human breast epithelial cells and malignant breast tissues: evidence for pathological activation of the IGF1R IRES.
    Blume SW, Jackson NL, Frost AR, Grizzle WE, Shcherbakov OD, Choi H, Meng Z.
    Exp Mol Pathol; 2010 Jun; 88(3):341-52. PubMed ID: 20233590
    [Abstract] [Full Text] [Related]

  • 25. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells.
    Karl M, Potier M, Schulman IH, Rivera A, Werner H, Fornoni A, Elliot SJ.
    Endocrinology; 2005 Feb; 146(2):889-900. PubMed ID: 15550505
    [Abstract] [Full Text] [Related]

  • 26. IFN-gamma-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors.
    Hu Y, Tan R, MacCalman CD, Eastabrook G, Park SH, Dutz JP, von Dadelszen P.
    Mol Hum Reprod; 2008 May; 14(5):281-9. PubMed ID: 18430759
    [Abstract] [Full Text] [Related]

  • 27. Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis.
    Forbes BE, Hartfield PJ, McNeil KA, Surinya KH, Milner SJ, Cosgrove LJ, Wallace JC.
    Eur J Biochem; 2002 Feb; 269(3):961-8. PubMed ID: 11846798
    [Abstract] [Full Text] [Related]

  • 28. Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation.
    Tian D, Mitchell I, Kreeger PK.
    BMC Syst Biol; 2016 Feb 09; 10():15. PubMed ID: 26861122
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Insulin-like growth factor-binding protein 7 regulates keratinocyte proliferation, differentiation and apoptosis.
    Nousbeck J, Sarig O, Avidan N, Indelman M, Bergman R, Ramon M, Enk CD, Sprecher E.
    J Invest Dermatol; 2010 Feb 09; 130(2):378-87. PubMed ID: 19710688
    [Abstract] [Full Text] [Related]

  • 33. WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.
    Kleer CG, Zhang Y, Pan Q, Merajver SD.
    Neoplasia; 2004 Feb 09; 6(2):179-85. PubMed ID: 15140407
    [Abstract] [Full Text] [Related]

  • 34. Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma.
    Zumsteg A, Caviezel C, Pisarsky L, Strittmatter K, García-Echeverría C, Hofmann F, Christofori G.
    Mol Cancer Res; 2012 Jun 09; 10(6):800-9. PubMed ID: 22562956
    [Abstract] [Full Text] [Related]

  • 35. Role of insulin-like growth factors in embryonic and postnatal growth.
    Baker J, Liu JP, Robertson EJ, Efstratiadis A.
    Cell; 1993 Oct 08; 75(1):73-82. PubMed ID: 8402902
    [Abstract] [Full Text] [Related]

  • 36. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
    Viereck V, Siggelkow H, Pannem R, Braulke T, Scharf JG, Kübler B.
    J Cell Biochem; 2007 Sep 01; 102(1):28-40. PubMed ID: 17372931
    [Abstract] [Full Text] [Related]

  • 37. IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
    Akiel M, Guo C, Li X, Rajasekaran D, Mendoza RG, Robertson CL, Jariwala N, Yuan F, Subler MA, Windle J, Garcia DK, Lai Z, Chen HH, Chen Y, Giashuddin S, Fisher PB, Wang XY, Sarkar D.
    Cancer Res; 2017 Aug 01; 77(15):4014-4025. PubMed ID: 28619711
    [Abstract] [Full Text] [Related]

  • 38. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 39. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
    Camidge DR, Dziadziuszko R, Hirsch FR.
    Clin Lung Cancer; 2009 Jul 15; 10(4):262-72. PubMed ID: 19632946
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.